The average one-year price target for Inspire Medical Systems (NYSE:INSP) has been revised to $113.99 / share. This is a decrease of 10.34% from the prior estimate of $127.13 dated November 7, 2025.

The average one-year price target for Inspire Medical Systems (NYSE:INSP) has been revised to $128.11 / share. This is an increase of 12.39% from the prior estimate of $113.99 dated November 14, 2025.

Fintel reports that on November 4, 2025, Truist Securities reiterated coverage of Inspire Medical Systems (NYSE:INSP) with a Hold recommendation. As of October 30, 2025, the average one-year price ...

Fintel reports that on November 4, 2025, Piper Sandler reiterated coverage of Inspire Medical Systems (NYSE:INSP) with a Overweight recommendation. As of October 30, 2025, the average one-year price ...

Fintel reports that on November 26, 2025, Truist Securities upgraded their outlook for Inspire Medical Systems (NYSE:INSP) from Hold to Buy. As of November 17, 2025, the average one-year price target ...

Fintel reports that on December 8, 2025, Oppenheimer upgraded their outlook for Inspire Medical Systems (NYSE:INSP) from Perform to Outperform. As of December 6, 2025, the average one-year price ...

Fintel reports that on November 4, 2025, Wells Fargo upgraded their outlook for Inspire Medical Systems (NYSE:INSP) from Equal-Weight to Overweight. As of October 30, 2025, the average one-year price ...

Fintel reports that on December 4, 2025, Baird maintained coverage of Inspire Medical Systems (NYSE:INSP) with a Outperform recommendation. As of November 17, 2025, the average one-year price target ...

Fintel reports that on December 23, 2025, UBS maintained coverage of Inspire Medical Systems (NYSE:INSP) with a Neutral recommendation. As of December 21, 2025, the average one-year price target for ...

Fintel reports that on October 15, 2025, Truist Securities maintained coverage of Inspire Medical Systems (NYSE:INSP) with a Hold recommendation. As of September 30, 2025, the average one-year price ...

Fintel reports that on November 24, 2025, Stifel upgraded their outlook for Inspire Medical Systems (NYSE:INSP) from Hold to Buy. As of November 17, 2025, the average one-year price target for Inspire ...